Lai, C-H <br/><br/>
HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer.  [electronic resource] 

 -  Oncogene  Oct 2014 
 - 4867-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2013.439  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Doxorubicin--pharmacology<br/>Drug Synergism<br/>G2 Phase Cell Cycle Checkpoints<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Inhibitory Concentration 50<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Nude<br/>Small Cell Lung Carcinoma--drug therapy<br/>Triazoles--pharmacology<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays